Transcriptomics

Dataset Information

0

Reversal of post-hepatectomy liver failure using a bioartifical liver supporting system implanted with clinical-grade human induced hepatocytes


ABSTRACT: Here, we developed a clinical-grade bioartificial liver (BAL) device by implanting with directly reprogrammed human hepatocytes (hiHep) manufactured and cryopreserved under current good manufacturing practice (cGMP) conditions. Notably, in a porcine PHLF model induced by 85% hepatectomy, hiHep-BAL treatment showed a remarkable survival benefit, as well as improvements of liver metabolic gene expression, ammonia detoxification, and liver regeneration. Furthermore, an investigator-initiated study in seven patients with extended liver resection (NCT05035108) demonstrated that hiHep-BAL treatment was well tolerated without complications and associated with ameliorative liver function and remarkable liver regeneration, meeting the primary outcome of safety and feasibility. These encouraging results warrant the further efficacy testing of hiHep-BAL for PHLF followed by the future broadening the patients eligible for liver resection in clinics.

ORGANISM(S): Sus scrofa

PROVIDER: GSE200124 | GEO | 2023/04/05

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2022-01-12 | GSE133271 | GEO
2013-01-01 | E-GEOD-14396 | biostudies-arrayexpress
2013-01-01 | GSE14396 | GEO
2019-05-20 | GSE115853 | GEO
2011-03-28 | E-GEOD-23696 | biostudies-arrayexpress
2011-03-28 | GSE23696 | GEO
2023-11-01 | GSE231391 | GEO
2010-01-03 | E-GEOD-14539 | biostudies-arrayexpress
2010-01-03 | GSE14539 | GEO
2023-09-27 | GSE232531 | GEO